» Articles » PMID: 37240017

The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 May 27
PMID 37240017
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamin D along with its active metabolite calcitriol and its metabolic and signaling system, known as the vitamin D endocrine system, have been widely recognized as a pivotal regulator of calcium homeostasis in addition to non-calcemic antitumoral effects in a variety of human cancers, including cervical cancer. Several studies have found an inverse relationship between the incidence of cervical neoplasia and vitamin D levels. This narrative review updates the current evidence supporting the notion that the vitamin D endocrine system has a preventive role on cervical cancer, mainly in the early phases of the disease, acting at the level of suppressing cell proliferation, promoting apoptosis, modulating inflammatory responses, and probably favoring the clearance of human papillomavirus-dependent cervical lesions. Although an optimal vitamin D status helps in the prevention and regression of low-grade squamous intraepithelial lesions of the cervix, it appears that vitamin D alone or combined with chemotherapeutic agents has little effectivity once advanced cervical cancer is established. These observations suggest that an optimal vitamin D status might exert beneficial actions in the early phases of cervical cancer by preventing its onset and progression.

Citing Articles

Biochemical mechanisms and molecular interactions of vitamins in cancer therapy.

Aborode A, Onifade I, Olorunshola M, Adenikinju G, Aruorivwooghene I, Femi A Cancer Pathog Ther. 2025; 3(1):3-15.

PMID: 39872372 PMC: 11764782. DOI: 10.1016/j.cpt.2024.05.001.


Vitamin D3 (Calcitriol) Monotherapy Decreases Tumor Growth, Increases Survival, and Correlates with Low Neutrophil-to-Lymphocyte Ratio in a Murine HPV-16-Related Cancer Model.

Hernandez-Rangel A, Hernandez-Fuentes G, Montes-Galindo D, Sanchez-Ramirez C, Cabrera-Licona A, Martinez-Fierro M Biomedicines. 2024; 12(6).

PMID: 38927564 PMC: 11201479. DOI: 10.3390/biomedicines12061357.


Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.

Wlodarczyk M, Ciebiera M, Nowicka G, Lozinski T, Ali M, Al-Hendy A Nutrients. 2024; 16(4).

PMID: 38398883 PMC: 10893337. DOI: 10.3390/nu16040559.


Vitamin D and Its Receptors in Cervical Cancer.

Dong H, Chen S, Liang X, Cai Q, Zhang X, Xie J J Cancer. 2024; 15(4):926-938.

PMID: 38230221 PMC: 10788714. DOI: 10.7150/jca.87499.


Relationship between human papillomavirus and serum vitamin D levels: a systematic review.

Khalili S, Rafiei E, Havaei M, Alizadeh L, Ghahremani F, Keshavarz Z BMC Infect Dis. 2024; 24(1):80.

PMID: 38216875 PMC: 10787408. DOI: 10.1186/s12879-024-09006-8.

References
1.
Norman A . Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147(12):5542-8. DOI: 10.1210/en.2006-0946. View

2.
Becker A, Fischer R, Schneider M . [Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus]. Z Rheumatol. 2002; 60(5):352-8. DOI: 10.1007/s003930170035. View

3.
Vahedpoor Z, Jamilian M, Bahmani F, Aghadavod E, Karamali M, Kashanian M . Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. Horm Cancer. 2017; 8(1):58-67. PMC: 10355858. DOI: 10.1007/s12672-016-0278-x. View

4.
Markowska A, Antoszczak M, Markowska J, Huczynski A . Role of Vitamin C in Selected Malignant Neoplasms in Women. Nutrients. 2022; 14(4). PMC: 8876016. DOI: 10.3390/nu14040882. View

5.
Cho G, Shin S, Kim H, Ha S, Kim S, Yoon J . HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis. BMC Cell Biol. 2007; 8:50. PMC: 2222240. DOI: 10.1186/1471-2121-8-50. View